BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22771408)

  • 21. Drug delivery via the mucous membranes of the oral cavity.
    Harris D; Robinson JR
    J Pharm Sci; 1992 Jan; 81(1):1-10. PubMed ID: 1619560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced drug delivery systems for local treatment of the oral cavity.
    Nguyen S; Hiorth M
    Ther Deliv; 2015; 6(5):595-608. PubMed ID: 26001175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buccal delivery of metformin: TR146 cell culture model evaluating the use of bioadhesive chitosan discs for drug permeability enhancement.
    Sander C; Nielsen HM; Jacobsen J
    Int J Pharm; 2013 Dec; 458(2):254-61. PubMed ID: 24148665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral transmucosal drug delivery--current status and future prospects.
    Sattar M; Sayed OM; Lane ME
    Int J Pharm; 2014 Aug; 471(1-2):498-506. PubMed ID: 24879936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developments in buccal drug delivery.
    de Vries ME; Boddé HE; Verhoef JC; Junginger HE
    Crit Rev Ther Drug Carrier Syst; 1991; 8(3):271-303. PubMed ID: 1954653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel strategies for the buccal delivery of macromolecules.
    Morales JO; McConville JT
    Drug Dev Ind Pharm; 2014 May; 40(5):579-90. PubMed ID: 24611816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug delivery from the oral cavity: a focus on mucoadhesive buccal drug delivery systems.
    Shinkar DM; Dhake AS; Setty CM
    PDA J Pharm Sci Technol; 2012; 66(5):466-500. PubMed ID: 23035030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mucoadhesive oral tablets--a modern dosage form with controlled drug release].
    Dostálová M; Rabisková M
    Ceska Slov Farm; 2000 Mar; 49(2):55-61. PubMed ID: 10953444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel tri-layered buccal mucoadhesive patch for drug delivery: assessment of nicotine delivery.
    Rao S; Song Y; Peddie F; Evans AM
    J Pharm Pharmacol; 2011 Jun; 63(6):794-9. PubMed ID: 21585377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation.
    Ikinci G; Senel S; Wilson CG; Sumnu M
    Int J Pharm; 2004 Jun; 277(1-2):173-8. PubMed ID: 15158980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oral films as perspective dosage form].
    Walicová V; Gajdziok J
    Ceska Slov Farm; 2016; 65(1):15-21. PubMed ID: 27118500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buccoadhesive drug delivery systems--extensive review on recent patents.
    Pathan SA; Iqbal Z; Sahani JK; Talegaonkar S; Khar RK; Ahmad FJ
    Recent Pat Drug Deliv Formul; 2008; 2(2):177-88. PubMed ID: 19075906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Formulation strategies of intraoral dosage forms].
    Kállai N; Sebestyén Z; Szabó B; Simon V; Antal I; Zelkó R
    Acta Pharm Hung; 2012; 82(3):95-103. PubMed ID: 23230648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucoadhesive oral films: The potential for unmet needs.
    Silva BM; Borges AF; Silva C; Coelho JF; Simões S
    Int J Pharm; 2015 Oct; 494(1):537-51. PubMed ID: 26315122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buccal drug delivery: what's new and what does the future hold?
    Giannola LI; De Caro V; Sutera FM
    Ther Deliv; 2014; 5(9):965-8. PubMed ID: 25375339
    [No Abstract]   [Full Text] [Related]  

  • 37. Mucoadhesive polymers-based film as a carrier system for sublingual delivery of glutathione.
    Chen G; Bunt C; Wen J
    J Pharm Pharmacol; 2015 Jan; 67(1):26-34. PubMed ID: 25303221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and in vitro characterization of an optimized porosity-enabled amalgamated matrix for sustained transbuccal drug delivery.
    Adeleke OA; Pillay V; du Toit LC; Choonara YE
    Int J Pharm; 2010 May; 391(1-2):79-89. PubMed ID: 20176095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Site-specific drug delivery systems II. Buccal delivery systems].
    Szente V; Zelkó R
    Acta Pharm Hung; 2007; 77(4):217-22. PubMed ID: 18290541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional variation in oral mucosal drug permeability.
    Kurosaki Y; Kimura T
    Crit Rev Ther Drug Carrier Syst; 2000; 17(5):467-508. PubMed ID: 11108157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.